← FDA DRUG APPROVALS

FDA ANDA · ANDA040245

CARISOPRODOL

Sponsor: CHARTWELL RX

APPLICATION
ANDA040245
TYPE
ANDA
ORIGINAL APPROVAL
1997-09-08
LATEST ACTION
2013-07-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CARISOPRODOLPrescription
CARISOPRODOL 350MG · TABLET · ORAL

Approval history

2013-07-26Labeling · Supplement 11 · standardAP
2011-05-24Labeling · Supplement 7AP
2009-01-29Labeling · Supplement 5AP
2006-11-29Labeling · Supplement 3AP
1997-09-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →